SUPPLEMENT
Q3 FY2026 — Non-GAAP reconciliation (Reg G)
Q3 FY2026PDF · 4 pages394 KB
1 The Procter & Gamble Company Regulation G Reconciliation of Non-GAAP Measures The following provides definitions of the non-GAAP measures used in Procter & Gamble's (“the Company”) April 24, 2026 earnings call, associated slides and other materials and the reconciliation to the most closely related GAAP measure. We believe that these non- GAAP measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by Management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of Management. Certain of these measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted. The Company is not able to reconcile its forward-looking non-GAAP cash flow and effective tax rate measures because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results. Note that certain columns and rows may not add due to rounding. The following measures are provided: 1. Organic sales growth — page 2 2. Core EPS and Currency-neutral Core EPS — page 3 3. Core gross margin and Currency-neutral Core gross margin — page 3 4. Core operating margin and Currency-neutral Core operating margin — page 4 5. Adjusted free cash flow and Adjusted free cash flow productivity — page 4 The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items: Incremental restructuring: The Company has historically had an ongoing level of restructuring activities of approximately $250 - $500 million before tax. On June 5, 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina. The adjustment to Core earnings includes the restructuring charges that exceed the normal, recurring level of restructuring charges. Glad joint venture agreement: In January 2026, the Glad joint venture agreement between the Company and Clorox expired. Under the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair market value, for $476 million. This transaction was accounted for as a dissolution of the Glad joint venture business and the Company recorded an after-tax gain of $261 million. Intangible asset impairment: In fiscal 2024, the Company recognized a non-cash, after-tax impairment charge of $1.0 billion ($1.3 billion before tax) to adjust the carrying value of the Gillette intangible asset acquired as part of the Company's 2005 acquisition of The Gillette Company. We do not view the above items to be part of our sustainable results, and their exclusion from Core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at- risk compensation. Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is also used in assessing the achievement of management goals for at-risk compensation. Core EPS and currency-neutral Core EPS: Core net earnings per share, or Core EPS, is a measure of diluted net earnings per common share (diluted EPS) adjusted for items as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange. Management views these non-GAAP measures as useful supplemental measures of Company performance over time. These measures are also used in assessing the achievement of management goals for at-risk compensation. -- 1 of 4 -- 2 Core gross margin and currency-neutral Core gross margin: Core gross margin is a measure of the Company's gross margin adjusted for items as indicated. Currency-neutral Core gross margin is a measure of the Company's Core gross margin excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the Company’s operating efficiency over time. Core operating margin and currency-neutral Core operating margin: Core operating margin is a measure of the Company's operating margin adjusted for items as indicated. Currency-neutral Core operating margin is a measure of the Company’s Core operating margin excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the Company’s operating efficiency over time. Adjusted free cash flow: Adjusted free cash flow is defined as operating cash flow less capital spending. Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments. Adjusted free cash flow productivity: Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the gain from the dissolution of the Glad joint venture business. We view adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. This measure is used by management in making operating decisions, allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation. 1. Organic sales growth: Three Months Ended March 31, 2026 Net Sales Growth Foreign Exchange Impact Acquisition & Divestiture Impact/Other* Organic Sales Growth Beauty 11% (4)% —% 7% Grooming 7% (6)% —% 1% Health Care 7% (5)% —% 2% Fabric Care & Home Care 7% (4)% —% 3% Baby, Feminine & Family Care 6% (3)% —% 3% Total Company 7% (4)% —% 3% * Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales. Prior Quarters Total Company Net Sales Growth Foreign Exchange Impact Acquisition/ Divestiture Impact/Other* Organic Sales Growth Q2 FY 2026 1% (1)% —% —% Q1 FY 2026 3% (1)% —% 2% Q4 FY 2025 2% —% —% 2% Q3 FY 2025 (2)% 2% 1% 1% Q2 FY 2025 2% —% 1% 3% Q1 FY 2025 (1)% 1% 2% 2% * Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales. Guidance Total Company Net Sales Growth Combined Foreign Exchange & Acquisition/Divestiture Impact/Other* Organic Sales Growth FY 2026 (Estimate) +1% to +5% -1% —% to +4% * Combined Foreign Exchange & Acquisition/Divestiture Impact/Other includes foreign exchange impacts, the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales. -- 2 of 4 -- 3 2. Core EPS and Currency-neutral Core EPS: Three Months Ended March 31 2026 2025 Diluted EPS $1.63 $1.54 Incremental restructuring 0.07 — Glad joint venture agreement (0.11) — Core EPS $1.59 $1.54 Percentage change vs. prior period Core EPS 3% Currency impact to earnings (0.05) Currency-Neutral Core EPS $1.54 Percentage change vs. prior period Core EPS — Prior Quarters Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction. Guidance Total Company Diluted EPS Growth Impact of Incremental Non-Core Items* Core EPS Growth Impact of FX Currency-neutral Core EPS Growth FY 2026 (Estimate) +1% to +6% -1% to -2% —% to +4% -1% -1% to +3% * Includes the impact of incremental non-core restructuring charges including the limited market portfolio restructuring with the substantial liquidation of its operations in Argentina incurred in fiscal 2025 and the incremental restructuring and gain from the dissolution of the Glad joint venture business in fiscal 2026. 3. Core gross margin and Currency-neutral Core gross margin: Three Months Ended March 31 2026 2025 Gross Margin 49.5% 51.0% Incremental restructuring 0.5% — Core Gross Margin 50.0% 51.0% Basis point change vs. prior year Core gross margin (100) Currency Impact to Margin — Currency-Neutral Core Gross Margin 50.0% Basis point change vs prior year Core gross margin (100) Q1 FY25 Q1 FY24 Q2 FY25 Q2 FY24 Q3 FY25 Q3 FY24 Q4 FY25 Q4 FY24 Q1 FY26 Q1 FY25 Q2 FY26 Q2 FY25 Diluted EPS $1.61 $1.83 $1.88 $1.40 $1.54 $1.52 $1.48 $1.27 $1.95 $1.61 $1.78 $1.88 Incremental restructuring 0.32 — — 0.02 — — — 0.13 0.04 0.32 0.10 — Intangible asset impairment — — — 0.42 — — — — — — — — Core EPS $1.93 $1.83 $1.88 $1.84 $1.54 $1.52 $1.48 $1.40 $1.99 $1.93 $1.88 $1.88 Percentage change 5% 2% 1% 6% 3% — Currency Impact to Earnings (0.02) 0.02 0.03 (0.01) — (0.03) Currency-Neutral Core EPS $1.91 $1.90 $1.57 $1.47 $1.99 $1.85 Percentage change vs. prior period Core EPS 4% 3% 3% 5% 3% (2)% -- 3 of 4 -- 4 4. Core operating margin and Currency-neutral Core operating margin: Three Months Ended March 31 2026 2025 Operating Margin 21.5% 23.0% Incremental restructuring 0.7% — Core Operating Margin 22.2% 23.0% Basis point change vs. prior year Core operating margin (80) Currency Impact to Margin 0.1% Currency-Neutral Core Operating Margin 22.3% Basis point change vs. prior year Core operating margin (70) 5. Adjusted free cash flow and Adjusted free cash flow productivity (dollar amounts in millions): Three Months Ended March 31, 2026 Operating Cash Flow Capital Spending Adjusted Free Cash Flow Net Earnings Adjustments to Net Earnings* Net Earnings as Adjusted Adjusted Free Cash Flow Productivity $4,045 $(1,019) $3,026 $3,951 $(261) $3,690 82% * Adjustments to Net earnings relate to the gain from the dissolution of the Glad joint venture business. -- 4 of 4 --